The human drug metabolizing cytochromes P450

被引:168
|
作者
Wrighton, SA
VandenBranden, M
Ring, BJ
机构
[1] Department of Drug Disposition, Eli Lilly and Company, Lilly Corporate Center, Indianapolis
来源
关键词
cytochrome P450; drug metabolism; hepatic; human; in vitro models;
D O I
10.1007/BF02353474
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The superfamily of heme-thiolate proteins known as the cytochromes P450 if responsible for the oxidative metabolism of the majority of drugs. Thus, the phenotypes of individuals with respect to their levels of catalytically active cytochromes P450 determines to a large part the substantial interindividual variation observed in the metabolic clearance of drugs. Over the past IO years IS different human cytochromes P450 involved in drug metabolism have been isolated and characterized to varying degrees. This brief review discusses the characterization of these cytochromes P450 and how this knowledge has been used by the pharmaceutical industry to aid in the development of new drugs.
引用
收藏
页码:461 / 473
页数:13
相关论文
共 50 条
  • [41] Sulfenylation of Human Liver and Kidney Microsomal Cytochromes P450 and Other Drug-Metabolizing Enzymes as a Response to Redox Alteration
    Albertolle, Matthew E.
    Phan, Thanh T. N.
    Pozzi, Ambra
    Guengerich, F. Peter
    MOLECULAR & CELLULAR PROTEOMICS, 2018, 17 (05) : 889 - 900
  • [42] Streptomyces cytochromes P450: applications in drug metabolism
    Lamb, David C.
    Waterman, Michael R.
    Zhao, Bin
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (10) : 1279 - 1294
  • [43] Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
    Zanger, Ulrich M.
    Turpeinen, Miia
    Klein, Kathrin
    Schwab, Matthias
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 392 (06) : 1093 - 1108
  • [44] Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
    Ulrich M. Zanger
    Miia Turpeinen
    Kathrin Klein
    Matthias Schwab
    Analytical and Bioanalytical Chemistry, 2008, 392 : 1093 - 1108
  • [45] Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450
    Yang, Ruirui
    Luo, Zhiqiang
    Liu, Yang
    Sun, Mohan
    Zheng, Ling
    Chen, Yingying
    Li, Yanping
    Wang, Hao
    Chen, Lingzhu
    Wu, Ming
    Zhao, Huihui
    CURRENT DRUG METABOLISM, 2016, 17 (07) : 681 - 691
  • [46] Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism
    Lewis, DFV
    Dickins, M
    DRUG METABOLISM REVIEWS, 2003, 35 (01) : 1 - 18
  • [47] Human drug metabolism and the cytochromes P450: Application and relevance of in vitro models
    Venkatakrishnan, K
    von Moltke, LL
    Greenblatt, DJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (11): : 1149 - 1179
  • [48] The Role of Arachidonic Acid Metabolizing Cytochromes P450 in the Control of Cardiovascular Functions
    Perepechaeva, M. L.
    Grishanova, A. Yu.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2024, 18 (03) : 192 - 213
  • [49] Introduction: Transcription and regulation of activities of cytochromes P450 metabolizing endogenous substrates
    Waterman, MR
    FASEB JOURNAL, 1996, 10 (13): : 1455 - 1455
  • [50] DrugMetZ DB: an anthology of human drug metabolizing Chytochrome P450 enzymes
    Antony, Tresa Remya Thomas
    Nagarajan, Shanthi
    BIOINFORMATION, 2006, 1 (07) : 248 - 250